BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1518 related articles for article (PubMed ID: 12029621)

  • 21. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
    Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
    Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of the type II transforming growth factor-beta receptor inhibits fibroblasts proliferation and activates extracellular signal regulated kinase and c-Jun N-terminal kinase.
    Goldberg HJ; Huszár T; Mózes MM; Rosivall L; Mucsi I
    Cell Biol Int; 2002; 26(2):165-74. PubMed ID: 11846446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells.
    Hsu YL; Kuo PL; Lin LT; Lin CC
    J Pharmacol Exp Ther; 2005 Apr; 313(1):333-44. PubMed ID: 15626723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential activation of c-Jun NH2-terminal kinase and p38 pathways during FTY720-induced apoptosis of T lymphocytes that is suppressed by the extracellular signal-regulated kinase pathway.
    Matsuda S; Minowa A; Suzuki S; Koyasu S
    J Immunol; 1999 Mar; 162(6):3321-6. PubMed ID: 10092785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells.
    Rousseau S; Houle F; Landry J; Huot J
    Oncogene; 1997 Oct; 15(18):2169-77. PubMed ID: 9393975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1.
    Naito T; Masaki T; Nikolic-Paterson DJ; Tanji C; Yorioka N; Kohno N
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F278-87. PubMed ID: 14583433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of rat hepatocyte proliferation by transforming growth factor beta and glucagon is associated with inhibition of ERK2 and p70 S6 kinase.
    Dixon M; Agius L; Yeaman SJ; Day CP
    Hepatology; 1999 May; 29(5):1418-24. PubMed ID: 10216124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of mitogen-activated protein kinase in Zn-BC-AM PDT-induced apoptosis in nasopharyngeal carcinoma cells.
    Koon HK; Chan PS; Wu ZG; Wong RN; Lung ML; Chang CK; Mak NK
    Cell Biochem Funct; 2010 Apr; 28(3):239-48. PubMed ID: 20373469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanical endothelial damage results in basic fibroblast growth factor-mediated activation of extracellular signal-regulated kinases.
    Pintucci G; Steinberg BM; Seghezzi G; Yun J; Apazidis A; Baumann FG; Grossi EA; Colvin SB; Mignatti P; Galloway AC
    Surgery; 1999 Aug; 126(2):422-7. PubMed ID: 10455916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.
    Xiao L; Lang W
    Cancer Res; 2000 Jan; 60(2):400-8. PubMed ID: 10667594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of nitric oxide-induced apoptotic death of HL-60 cells by protein kinase C and protein kinase A through mitogen-activated protein kinases and CPP32-like protease pathways.
    Jun CD; Pae HO; Kwak HJ; Yoo JC; Choi BM; Oh CD; Chun JS; Paik SG; Park YH; Chung HT
    Cell Immunol; 1999 May; 194(1):36-46. PubMed ID: 10357879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinoic acid inhibits hepatic Jun N-terminal kinase-dependent signaling pathway in ethanol-fed rats.
    Chung J; Chavez PR; Russell RM; Wang XD
    Oncogene; 2002 Feb; 21(10):1539-47. PubMed ID: 11896582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway.
    Chen RH; Su YH; Chuang RL; Chang TY
    Oncogene; 1998 Oct; 17(15):1959-68. PubMed ID: 9788439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Teratogen-induced activation of ERK, JNK, and p38 MAP kinases in early postimplantation murine embryos.
    Mirkes PE; Wilson KL; Cornel LM
    Teratology; 2000 Jul; 62(1):14-25. PubMed ID: 10861629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oleylamine (long-chain fatty amine)-induced cell death through MAP kinase pathways in human pancreatic cancer cells].
    Mizukami Y
    Hokkaido Igaku Zasshi; 2002 Jan; 77(1):17-29. PubMed ID: 11868368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mixed lineage kinase 3 (MLK3)-activated p38 MAP kinase mediates transforming growth factor-beta-induced apoptosis in hepatoma cells.
    Kim KY; Kim BC; Xu Z; Kim SJ
    J Biol Chem; 2004 Jul; 279(28):29478-84. PubMed ID: 15069087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.
    Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trichostatin a prevents TGF-beta1-induced apoptosis by inhibiting ERK activation in human renal tubular epithelial cells.
    Yoshikawa M; Hishikawa K; Idei M; Fujita T
    Eur J Pharmacol; 2010 Sep; 642(1-3):28-36. PubMed ID: 20553909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silica-induced TNF-alpha and TGF-beta1 expression in RAW264.7 cells are dependent on Src-ERK/AP-1 pathways.
    Li X; Hu Y; Jin Z; Jiang H; Wen J
    Toxicol Mech Methods; 2009 Jan; 19(1):51-8. PubMed ID: 19778233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of mitogen-activated protein kinases and phosphorylation of Bcl-2 by vinblastine represent persistent forms of normal fluctuations at G2-M1.
    Fan M; Du L; Stone AA; Gilbert KM; Chambers TC
    Cancer Res; 2000 Nov; 60(22):6403-7. PubMed ID: 11103805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 76.